Pharmaceutical Control of the
Human Microbiome

Board of Directors

Ward Peterson, PhD
Co-founder, President and CEO

Dr. Peterson has 16 years experience in pharma R&D—drug discovery to Phase 3 studies involving multiple targets and therapeutic areas. His previous employment was with Regeneron Pharmaceuticals and Inspire Pharmaceuticals (Research Scientist to Senior VP).

Matthew Redinbo, PhD
Co-founder and Chief Scientific Officer
Dr. Redinbo is the inventor of Symberix's technology licensed from University of North Carolina, Chapel Hill. He has 25 years of experience in biochemistry, structural and chemical biology. Dr. Redinbo is the Kenan Distinguished Professor of Chemistry, Biochemistry, Microbiology and Genomics at UNC, Chapel Hill.
Kay Wagoner, PhD
President, Wagoner Discovery and Development Consulting, LLC
Dr. Wagoner has over 25 years of experience as a leader and teacher in health care, university education, drug discovery and drug development. She is an Adjunct Associate Professor in the UNC School of Medicine’s Department of Cell and Molecular Physiology and serves as Entrepreneur in Residence with the Blackstone Entrepreneurs Network. Dr. Wagoner founded and served as President, Director and CEO of Icagen, Inc., a publicly-traded biopharmaceutical company acquired by Pfizer, Inc.